Literature DB >> 19350051

Vitamin D and prostate cancer risk: a review of the epidemiological literature.

D Gupta1, C A Lammersfeld, K Trukova, C G Lis.   

Abstract

Prostate cancer is the most commonly diagnosed cancer in the United States. Prostate cells contain vitamin D receptors as well as enzymes necessary for vitamin D metabolism. Vitamin D metabolites have an antiproliferative and a pro-differentiating effect on prostate cancer cell lines in vitro and in vivo. As a result, there has been an emerging interest in the potential role of vitamin D in the etiology of prostate cancer. This review summarizes all available epidemiological literature on the association between dietary vitamin D, circulating levels of vitamin D and sunlight exposure in relation to prostate cancer risk. To place these studies in context, we also provide some background information on vitamin D, such as its dietary sources, metabolism, optimal levels, hypovitaminosis and relationship with the prostate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350051     DOI: 10.1038/pcan.2009.7

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  20 in total

1.  Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers.

Authors:  William B Grant; Johan E Moan; Emanuela Micu; Alina C Porojnicu; Asta Juzeniene
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-11

Review 3.  Novel targets for prostate cancer chemoprevention.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

4.  Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Authors:  Whitney K Hendrickson; Richard Flavin; Julie L Kasperzyk; Michelangelo Fiorentino; Fang Fang; Rosina Lis; Christopher Fiore; Kathryn L Penney; Jing Ma; Philip W Kantoff; Meir J Stampfer; Massimo Loda; Lorelei A Mucci; Edward Giovannucci
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption and urban/rural residence.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2010-04

6.  [Non dietetic environmental risk factors in prostate cancer].

Authors:  J Ferrís-I-Tortajada; O Berbel-Tornero; J Garcia-I-Castell; J A López-Andreu; E Sobrino-Najul; J A Ortega-García
Journal:  Actas Urol Esp       Date:  2011-03-24       Impact factor: 0.994

Review 7.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

8.  The Association Between the Genetic VDR SNP c.907+75C>T and Prostate Cancer Risk Is Modified by Tanning Potential.

Authors:  Desta A Beyene; Mohammad R Daremipouran; Victor Apprey; Tammey Naab; Olakunle O Kassim; Robert L Copeland; Yasmine M Kanaan
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

Review 9.  DHPLC Elution Patterns of VDR PCR Products Can Predict Prostate Cancer Susceptibility in African American Men.

Authors:  Robert L Copeland; Desta Beyene; Victor Apprey; Mohammad R Daremipouran; Tammey J Naab; Olakunle O Kassim; Yasmine M Kanaan
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

10.  Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.

Authors:  Stephanie J Weinstein; Alison M Mondul; William Kopp; Helen Rager; Jarmo Virtamo; Demetrius Albanes
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.